English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Development of GPC3-CAR-NK cells and optimization as a therapy for HCC Journal article
Cao, Bihui, Ni, Qianqian, Chen, Zhuxin, Yang, Shuo, Zhang, Xinkui, Su, Haotao, Zheng, Zhenfeng, Zhao, Qi, Zhu, Xiaolan, Liu, Manting. Development of GPC3-CAR-NK cells and optimization as a therapy for HCC[J]. Journal of leukocyte biology, 2024, 0(0), 1-11.
Authors:  Cao, Bihui;  Ni, Qianqian;  Chen, Zhuxin;  Yang, Shuo;  Zhang, Xinkui; et al.
Favorite | TC[WOS]:0  | Submit date：2024/08/20
Hcc  Mwa  Chimeric Antigen Receptor  Glypican-3  Natural Killer.  
“Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment Journal article
Guowang Cheng, Zhongjun Li, Yujing Liu, Rui Ma, Xiaojia Chen, Wen Liu, Yafang Song, Yuan Zhang, Guangtao Yu, Zhenfeng Wu, Tongkai Chen. “Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment[J]. Journal of Controlled Release, 2022, 353, 752-766.
Authors:  Guowang Cheng;  Zhongjun Li;  Yujing Liu;  Rui Ma;  Xiaojia Chen; et al.
Favorite | TC[WOS]:11 TC[Scopus]:13  IF:10.5/10.6 | Submit date：2023/02/01
Parkinson's Disease  Neuroinflammation  Α-synuclein  Blood-brain Barrier  Black Phosphorus Nanosheets  Neuroprotection  
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer Journal article
Cao, Bihui, Liu, Manting, Wang, Lu, Zhu, Kangshun, Cai, Mingyue, Chen, Xiaopei, Feng, Yunfei, Yang, Shuo, Fu, Shengyu, Zhi, Cheng, Ye, Xiaodie, Zhang, Jian, Zhang, Zhiru, Yang, Xin, Zhao, Ming, Wu, Qingde, Xu, Linfeng, Yang, Lili, Lian, Hui, Zhao, Qi, Zhang, Zhenfeng. Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer[J]. Nature Communications, 2022, 13(1), 6203.
Authors:  Cao, Bihui;  Liu, Manting;  Wang, Lu;  Zhu, Kangshun;  Cai, Mingyue; et al.
Favorite | TC[WOS]:48 TC[Scopus]:48  IF:14.7/16.1 | Submit date：2023/01/30
Growth  Antibody  Thermal Ablation  Receptor Tyrosine Kinases  
CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo Journal article
Liu, Manting, Huang, Wensou, Guo, Yongjian, Zhou, Yubo, Zhi, Cheng, Chen, Jingwu, Li, Junping, He, Jinping, Lian, Hui, Zhou, Jingwen, Ye, Xiaodie, Hu, Yuling, Hu, Hong, Liu, Zhaoyuan, Huang, Jingjun, Lin, Liteng, Cai, Mingyue, Wang, Xiaobin, Huang, Jingzhen, Zhang, Zhenfeng, Zhu, Kangshun, Zhao, Qi, Cao, Bihui. CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo[J]. Journal of Leukocyte Biology, 2022, 112(4), 901-911.
Authors:  Liu, Manting;  Huang, Wensou;  Guo, Yongjian;  Zhou, Yubo;  Zhi, Cheng; et al.
Favorite | TC[WOS]:38 TC[Scopus]:35  IF:3.6/5.2 | Submit date：2022/05/17
Chimeric Antigen Receptor  Delta-like Ligand 3  Nk-92 Cells  Sclc  
Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors Journal article
Jiang, Zhiwu, Cheng, Lin, Wu, Zhiping, Zhou, Linfu, Wang, Haitao, Hong, Qilan, Wu, Qiting, Long, Youguo, Huang, Yunlin, Xu, Gaoqi, Yao, Yao, Tang, Zhaoyang, Zhang, Zhenfeng, Yang, Lili, Luo, Wei, Yang, Jie, Gong, Likun, Liu, Pentao, Chen, Xinwen, Cui, Shuzhong, Zhang, Qi, Li, Yinxiong, Li, Peng. Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors[J]. EMBO Reports, 2022, 23(6), e54275.
Authors:  Jiang, Zhiwu;  Cheng, Lin;  Wu, Zhiping;  Zhou, Linfu;  Wang, Haitao; et al.
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:6.5/8.3 | Submit date：2022/05/17
Biomarkers  Hepatocellular Carcinoma  Humanized Mouse Models  Immunotherapy  Oncogenes  
Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer Journal article
Yang,Shuo, Cao,Bihui, Zhou,Guangyu, Zhu,Lipeng, Wang,Lu, Zhang,Li, Kwok,Hang Fai, Zhang,Zhenfeng, Zhao,Qi. Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer[J]. Frontiers in Pharmacology, 2020, 11, 1089.
Authors:  Yang,Shuo;  Cao,Bihui;  Zhou,Guangyu;  Zhu,Lipeng;  Wang,Lu; et al.
Favorite | TC[WOS]:45 TC[Scopus]:48  IF:4.4/5.0 | Submit date：2021/03/04
B7-h3  Chimeric Antigen Receptor  Immune Checkpoint  Natural Killer Cell  Nk-92